#FactorXA - Twitter Hashtag

10 months ago

CSL Behring Have Announced a Collaboration with Dutch Biotech, VarmX - @richardbuka https://t.co/qRsingKMOu #Apixaban #DutchBiotech #FactorXa #MedED #FactorX #NovelBypassingAgent #Inhibition #Health #Hematology #Hemostasis #HemostasisToday #MedX #Medicine #Rivaroxaban #Thrombosis #VMXC001

HemostasisToday's tweet photo. CSL Behring Have Announced a Collaboration with Dutch Biotech, VarmX - @richardbuka

https://t.co/qRsingKMOu

#Apixaban #DutchBiotech #FactorXa #MedED #FactorX #NovelBypassingAgent #Inhibition #Health #Hematology #Hemostasis #HemostasisToday #MedX #Medicine #Rivaroxaban #Thrombosis #VMXC001

0

3

0

75

ISTH

@isth

almost 2 years ago

Swipe to reveal the correct answer to this poll! 🎉 Want to dive deeper? Join us for our upcoming webinar, “Monitoring and Reversal for Factor Xa Inhibitors,” to learn more. Register now: https://t.co/UWbAAINToJ. #HealthcareWebinar #FactorXa #VTEAwareness

isth's tweet photo. Swipe to reveal the correct answer to this poll! 🎉 Want to dive deeper? Join us for our upcoming webinar, “Monitoring and Reversal for Factor Xa Inhibitors,” to learn more. Register now: https://t.co/UWbAAINToJ. #HealthcareWebinar #FactorXa #VTEAwareness https://t.co/nLLPlqPxpH

0

3

0

386

Thrombosis Update @ThrombUpdate

almost 2 years ago

In this recent @ThrombUpdate article, the authors systematically reviewed the literature to determine the efficacy and safety of #FactorXa inhibitors in managing #HIT (heparin-induced thrombocytopenia) Read more here: https://t.co/Aqb6CkK6w3 #ThrJournal @LucyNORTCD @EmmPapa

ThrombUpdate's tweet photo. In this recent @ThrombUpdate article, the authors systematically reviewed the literature to determine the efficacy and safety of #FactorXa inhibitors in managing #HIT (heparin-induced thrombocytopenia)

Read more here:
https://t.co/Aqb6CkK6w3

#ThrJournal
@LucyNORTCD @EmmPapa https://t.co/IMouS6FOZE

0

4

1

188

Harriette Van Spall, MD MPH 🇨🇦 @hvanspall

over 3 years ago

Invictus aimed to assess noninferiority of #FactorXa inhib #rivaroxaban 20 mg vs dose adjusted #VKA ♥️ VKA ⬇️ composite CV events or death vs Riva ♥️VKA ⬇️ death (mainly #HF deaths) ♥️ more permanent discontinuation w/ riva, but findings consistent in on-treatment analysis 3/

hvanspall's tweet photo. Invictus aimed to assess noninferiority of #FactorXa inhib #rivaroxaban 20 mg vs dose adjusted #VKA
♥️ VKA ⬇️ composite CV events or death vs Riva
♥️VKA ⬇️ death (mainly #HF deaths)
♥️ more permanent discontinuation w/ riva, but findings consistent in on-treatment analysis 3/ https://t.co/ZfLvzthLTK

1

8

1

1K

John P Erwin III MD MBA MACC (#BigPoppy )

@HeartOTXHeartMD

over 3 years ago

Andexanet Alfa for Major Bleeding w #FactorXa Inhibitors Use of andexanet alfa was associated with a high degree of good/excellent hemostatic efficacy in pts w FXa inhibitor-assoc major bleeding. Rate of thrombotic events was 10% after #AndexanetAlfa https://t.co/x95bCWWRr6

0

8

0

2K

cardio-met

@cardiomet_CE

over 3 years ago

6) The #ANNEXA-4 (https://t.co/gojwnuaj5U) investigators evaluated #Andexanet in an open-label single-group study of 67 pts with acute major bleeding (mostly #GI and #intracranial) ≤ 18h after administration of a #factorXa inhibitor.

1

4

0

ACCP CRIT PRN @accpcritprn

about 5 years ago

Look at this brilliant editorial by @MikeA_42 on evidence for andexanet alfa in reversing ICH due to Factor Xa inhibitors! #critPRN #PharmICU #FactorXa https://t.co/PgLaDOeKKm

0

16

4

7

0

HemoSonics @HemoSonics

almost 7 years ago

Anti-FactorXa-Based #Anticoagulation during #Extracorporeal Membrane Oxygenation: Potential Problems and Possible Solutions. - https://t.co/PEhSCLushC #ECMO #FactorXA #heparin

0

1

0

Internal Medicine @pgMedicine

almost 7 years ago

💊 #FactorXa inhibitor #Rivaroxaban as effective as Warfarin (#vitK inhibitor) But When body weight is >120 kg the the effect of factor Xa inhibitors are significantly reduce & #warfarin is drug of choice in that #foamed #medEd #mrcp #cardiology #cardiotwitter #medicine #usmle

0

1

0

Deepak Sudheendra, MD, MHCI, RPVI, FSIR

@Dr_Sudi

over 7 years ago

Do you know the “antidote” for meds you prescribe? This info/dosage should be memorized or within easy reach. If you use #factorXa inhibitors #xarelto #eliquis #savaysa, be familiar w/#AndexanetAlpha to stop major bleeding. @ThromboAdviser @CMichaelGibson @somedocs @NEJM @SIRRFS

Dr_Sudi's tweet photo. Do you know the “antidote” for meds you prescribe? This info/dosage should be memorized or within easy reach. If you use #factorXa inhibitors #xarelto #eliquis #savaysa, be familiar w/#AndexanetAlpha to stop major bleeding. @ThromboAdviser @CMichaelGibson @somedocs @NEJM @SIRRFS https://t.co/pVp9GcwXZE

0

5

2

0

For scientific exchange without fraud @SanLi_today

over 7 years ago

#BMS/#Pfizer anticoagulant #Eliquis (#apixaban), a #FactorXa inhibitor 'Clinical Trial Fraud Uncovered https://t.co/WwQALmIhwT

Retraction Watch @RetractionWatch

over 7 years ago

"Four years after his paper named a host of potentially-flawed papers...@cgseife said he was unaware of any cases where the journals that published those studies have retracted them or alerted their readers to a potential problem." https://t.co/fkNRLQEV7t

0

7

6

0

1

0

Harriette Van Spall, MD MPH 🇨🇦 @hvanspall

over 7 years ago

Important study from Connolly, ⁦@crowthrm⁩, Eikelboom al from ⁦@PHRIresearch⁩ & ⁦@MacDeptMed⁩ in ⁦@NEJM⁩. #AndexanetAlfa to treat bleeding associated with #FactorXa Inhibitors | NEJM. https://t.co/hS8K1XWJ6d

1

11

3

0